LDTs
Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal
Under the five-year exclusive agreement, Artemis DNA will offer Datar Cancer Genetics' Trucheck Pragma and Cancertrack tests in the US and Vietnam.
Having officially launched its Shield colorectal cancer screening assay as an LDT, Guardant stands to benefit from a head start in clinical establishment.
Genetron Health Q4 Revenues Up 10 Percent
The company's IVD sales revenue rose significantly, offsetting a quarter-over-quarter drop in revenue from in-house LDT serves.
ACMG Survey Finds Laboratory Geneticists Have Concerns Over Proposed Changes to LDT Regulation
Lab geneticists are raising concerns as the US Congress is expected to take up a bill that would change how the Food and Drug Administration oversees LDTs.
Precipio Hematologic Malignancy Test Receives NY State Approval
The Hemescreen test uses proprietary high resolution melt technology and can now be used in labs in New York as a laboratory developed test.